We are live on
!
Find out more
3C
325 Capital Portfolio holdings
AUM
$419M
1-Year Est. Return
75.74%
This Fund
S&P 500
This Quarter
Est. Return
+22.83%
1 Year Est. Return
+75.74%
3 Year Est. Return
+225.71%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$329M
AUM Growth
+$75.7M
(+30%)
Cap. Flow
+$23.7M
Cap. Flow
% of AUM
7.19%
Top 10 Holdings %
Top 10 Hldgs %
96.5%
Holding
12
New
1
Increased
1
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Magnite
MGNI
|
+$15.3M |
| 2 |
Astrana Health
ASTH
|
+$8.32M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 38.64% |
| 2 | Healthcare | 19.27% |
| 3 | Consumer Staples | 18.33% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Technology | 9.31% |
Similar funds
PWA
BA
UOC
RBFC
LSWP
XWM
NTCM
DAS
325 Capital's Q3 2025 Portfolio in Review
As of Q3 2025, 325 Capital held 12 positions worth $329M, up 30% from $253M the previous quarter. Its ten largest holdings account for 96% of the portfolio.
325 Capital deployed $23.7M of net new capital in Q3 2025, opening 1 new position and adding to 1 existing holding. Its largest new stake was Magnite: 650,061 shares worth $14.2M.
By sector, the portfolio is most concentrated in Industrials at 39% of assets, down from 40% a quarter earlier, followed by Healthcare and Consumer Staples.
- 325 Capital's largest Q3 2025 buy was Magnite: 650,061 shares worth $14.2M.
- 325 Capital added most to Astrana Health in Q3 2025, an estimated $8.32M increase.
- 325 Capital's ten largest holdings make up 96% of its $329M portfolio in Q3 2025.
- 325 Capital opened 1 new position and closed 0 in Q3 2025.
- 325 Capital's portfolio value rose 30% quarter-over-quarter to $329M.
Based on 325 Capital's 13F filing for Q3 2025, filed 14 Nov 2025.